{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:54:36Z","timestamp":1789512876119,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/ijir.2016.24","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T08:02:44Z","timestamp":1464854564000},"page":"161-166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["A meta-analysis of extracorporeal shock wave therapy for Peyronie\u2019s disease"],"prefix":"10.1038","volume":"28","author":[{"given":"L","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"key":"BFijir201624_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ncpuro0201","volume":"2","author":"NF Gonzalez-Cadavid","year":"2005","unstructured":"Gonzalez-Cadavid NF, Rajfer J . Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie's disease. Nat Clin Pract Urol 2005; 2: 291\u2013297.","journal-title":"Nat Clin Pract Urol"},{"key":"BFijir201624_CR2","first-page":"128","volume":"82","author":"E De Berardinis","year":"2010","unstructured":"De Berardinis E, Busetto GM, Antonini G, Giovannone R, Gentile V . Extracorporeal shock wave therapy in the treatment of Peyronie's disease: long-term results. Arch Ital Urol Androl 2010; 82: 128\u2013133.","journal-title":"Arch Ital Urol Androl"},{"key":"BFijir201624_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.eururo.2012.05.040","volume":"62","author":"K Hatzimouratidis","year":"2012","unstructured":"Hatzimouratidis K, Eardley I, Giuliano F, Hatzichristou D, Moncada I, Salonia A et al. EAU guidelines on penile curvature. Eur Urol 2012; 62: 543\u2013552.","journal-title":"Eur Urol"},{"key":"BFijir201624_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0090-4295(02)01527-3","volume":"59","author":"T Lebret","year":"2002","unstructured":"Lebret T, Loison G, Herve JM, Mc Eleny KR, Lugagne PM, Yonneau L et al. Extracorporeal shock wave therapy in the treatment of Peyronie's disease: experience with standard lithotriptor (siemens-multiline). Urology 2002; 59: 657\u2013661.","journal-title":"Urology"},{"key":"BFijir201624_CR5","first-page":"417","volume":"61","author":"C Bellorofonte","year":"1989","unstructured":"Bellorofonte C, Ruoppolo M, Tura M, Zaatar C, Tombolini P, Menchini Fabris GF . Possibility of using the piezoelectric lithotriptor in the treatment of severe cavernous fibrosis. Arch Ital Urol Nefrol Androl 1989; 61: 417\u2013422.","journal-title":"Arch Ital Urol Nefrol Androl"},{"key":"BFijir201624_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000020013","volume":"36","author":"V Mirone","year":"1999","unstructured":"Mirone V, Imbimbo C, Palmieri A, Fusco F . Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica. Eur Urol 1999; 36: 327\u2013330.","journal-title":"Eur Urol"},{"key":"BFijir201624_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1159\/000020359","volume":"38","author":"EW Hauck","year":"2000","unstructured":"Hauck EW, Altinkilic BM, Ludwig M, Ludecke G, Schroeder-Printzen I, Arens C et al. Extracorporal shock wave therapy in the treatment of Peyronie's disease. First results of a case-controlled approach. Eur Urol 2000; 38: 663\u2013669.","journal-title":"Eur Urol"},{"key":"BFijir201624_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1745-7262.2006.00138.x","volume":"8","author":"V Poulakis","year":"2006","unstructured":"Poulakis V, Skriapas K, de Vries R, Dillenburg W, Ferakis N, Witzsch U et al. Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment? Asian J Androl 2006; 8: 361\u2013366.","journal-title":"Asian J Androl"},{"key":"BFijir201624_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.eururo.2009.05.012","volume":"56","author":"A Palmieri","year":"2009","unstructured":"Palmieri A, Imbimbo C, Longo N, Fusco F, Verze P, Mangiapia F et al. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease. Eur Urol 2009; 56: 363\u2013369.","journal-title":"Eur Urol"},{"key":"BFijir201624_CR10","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/j.1464-410X.2010.09331.x","volume":"106","author":"S Chitale","year":"2010","unstructured":"Chitale S, Morsey M, Swift L, Sethia K . Limited shock wave therapy vs sham treatment in men with Peyronie's disease: results of a prospective randomized controlled double-blind trial. BJU Int 2010; 106: 1352\u20131356.","journal-title":"BJU Int"},{"key":"BFijir201624_CR11","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1111\/jsm.12275","volume":"10","author":"G Hatzichristodoulou","year":"2013","unstructured":"Hatzichristodoulou G, Meisner C, Gschwend JE, Stenzl A, Lahme S . Extracorporeal shock wave therapy in Peyronie's disease: results of a placebo-controlled, prospective, randomized, single-blind study. J Sex Med 2013; 10: 2815\u20132821.","journal-title":"J Sex Med"},{"key":"BFijir201624_CR12","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","volume":"171","author":"JP Mulhall","year":"2004","unstructured":"Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A et al. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol 2004; 171: 2350\u20132353.","journal-title":"J Urol"},{"key":"BFijir201624_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.ijir.3901518","volume":"19","author":"M Arafa","year":"2007","unstructured":"Arafa M, Eid H, El-Badry A, Ezz-Eldine K, Shamloul R . The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction. Int J Impot Res 2007; 19: 213\u2013217.","journal-title":"Int J Impot Res"},{"key":"BFijir201624_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1365-2605.2011.01226.x","volume":"35","author":"A Palmieri","year":"2012","unstructured":"Palmieri A, Imbimbo C, Creta M, Verze P, Fusco F, Mirone V . Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial. Int J Androl 2012; 35: 190\u2013195.","journal-title":"Int J Androl"},{"key":"BFijir201624_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4081\/aiua.2015.1.20","volume":"87","author":"C Pavone","year":"2015","unstructured":"Pavone C, D'Amato F, Dispensa N, Torretta F, Magno C . Smoking, diabetes, blood hypertension: possible etiologic role for Peyronie's disease? Analysis in 279 patients with a control group in Sicily. Arch Ital Urol Androl 2015; 87: 20\u201324.","journal-title":"Arch Ital Urol Androl"},{"key":"BFijir201624_CR16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4103\/1008-682X.142130","volume":"17","author":"MJ Choi","year":"2015","unstructured":"Choi MJ, Song KM, Park JM, Kwon MH, Kwon KD, Park SH et al. Effect of SMAD7 gene overexpression on TGF-beta1-induced profibrotic responses in fibroblasts derived from Peyronie's plaque. Asian J Androl 2015; 17: 487\u2013492.","journal-title":"Asian J Androl"},{"key":"BFijir201624_CR17","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","volume":"175","author":"JP Mulhall","year":"2006","unstructured":"Mulhall JP, Schiff J, Guhring P . An analysis of the natural history of Peyronie's disease. J Urol 2006; 175: 2115\u20132118.","journal-title":"J Urol"},{"key":"BFijir201624_CR18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1046\/j.1464-410X.2000.00827.x","volume":"86","author":"J Husain","year":"2000","unstructured":"Husain J, Lynn NN, Jones DK, Collins GN, O'Reilly PH . Extracorporeal shock wave therapy in the management of Peyronie's disease: initial experience. BJU Int 2000; 86: 466\u2013468.","journal-title":"BJU Int"},{"key":"BFijir201624_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1046\/j.1442-2042.2002.00430.x","volume":"9","author":"H Kiyota","year":"2002","unstructured":"Kiyota H, Ohishi Y, Asano K, Hasegawa N, Madarame J, Miki K et al. Extracorporeal shock wave treatment for Peyronie's disease using EDAP LT-02; preliminary results. Int J Urol 2002; 9: 110\u2013113.","journal-title":"Int J Urol"},{"key":"BFijir201624_CR20","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0090-4295(02)01970-2","volume":"60","author":"R Manikandan","year":"2002","unstructured":"Manikandan R, Islam W, Srinivasan V, Evans CM . Evaluation of extracorporeal shock wave therapy in Peyronie's disease. Urology 2002; 60: 795\u2013799.","journal-title":"Urology"},{"key":"BFijir201624_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/01.ju.0000099891.68488.4e","volume":"171","author":"EW Hauck","year":"2004","unstructured":"Hauck EW, Hauptmann A, Bschleipfer T, Schmelz HU, Altinkilic BM, Weidner W . Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach. J Urol 2004; 171: 296\u2013299.","journal-title":"J Urol"},{"key":"BFijir201624_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/sj.ijir.3901192","volume":"16","author":"RT Strebel","year":"2004","unstructured":"Strebel RT, Suter S, Sautter T, Hauri D . Extracorporeal shockwave therapy for Peyronie's disease does not correct penile deformity. Int J Impot Res 2004; 16: 448\u2013451.","journal-title":"Int J Impot Res"},{"key":"BFijir201624_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3109\/21681805.2014.984326","volume":"49","author":"AB Olsen","year":"2015","unstructured":"Olsen AB, Persiani M, Boie S, Hanna M, Lund L . Can low-intensity extracorporeal shockwave therapy improve erectile dysfunction? A prospective, randomized, double-blind, placebo-controlled study. Scand J Urol 2015; 49: 329\u2013333.","journal-title":"Scand J Urol"},{"key":"BFijir201624_CR24","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/iju.12506","volume":"21","author":"CH Yee","year":"2014","unstructured":"Yee CH, Chan ES, Hou SS, Ng CF . Extracorporeal shockwave therapy in the treatment of erectile dysfunction: a prospective, randomized, double-blinded, placebo controlled study. Int J Urol 2014; 21: 1041\u20131045.","journal-title":"Int J Urol"},{"key":"BFijir201624_CR25","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.juro.2011.12.117","volume":"187","author":"Y Vardi","year":"2012","unstructured":"Vardi Y, Appel B, Kilchevsky A, Gruenwald I . Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J Urol 2012; 187: 1769\u20131775.","journal-title":"J Urol"},{"key":"BFijir201624_CR26","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/01.ju.0000108060.30363.8d","volume":"171","author":"EW Hauck","year":"2004","unstructured":"Hauck EW, Mueller UO, Bschleipfer T, Schmelz HU, Diemer T, Weidner W . Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of clinical trials. J Urol 2004; 171: 740\u2013745.","journal-title":"J Urol"},{"key":"BFijir201624_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.eururo.2007.06.032","volume":"53","author":"A Muller","year":"2008","unstructured":"Muller A, Akin-Olugbade Y, Deveci S, Donohue JF, Tal R, Kobylarz KA et al. The impact of shock wave therapy at varied energy and dose levels on functional and structural changes in erectile tissue. Eur Urol 2008; 53: 635\u2013642.","journal-title":"Eur Urol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ijir201624.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijir201624","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijir201624.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T18:34:37Z","timestamp":1692383677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijir201624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["BFijir201624"],"URL":"https:\/\/doi.org\/10.1038\/ijir.2016.24","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,2]]},"assertion":[{"value":"6 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}